One in three people is at risk for diabetes. So 23andMe set out to develop the first direct-to-consumer genetic test to assess whether its users have a higher likelihood of developing type 2 diabetes, which is the most common form of the disease.
Esperion’s experimental treatment for lowering cholesterol is poised to help millions of patients, CEO Tim Mayleben told CNBC on Wednesday.
Air pollution could be to blame for up to 33 million emergency asthma attack visits to hospital a year, a world study involving the University of York has found. It is the first study to estimate the impact of air pollution on asthma cases across the globe. Asthma is the most prevalent chronic respiratory disease worldwide, affecting… Read More »